Deutsch
English
MCUSTOM_CHOICEVARIANTS
Helipur H plus N
Gentle disinfection of thermolabile articles, such as endoscopes or plastic instruments. Broad spectrum of activity, very economical due to low application concentrations.
- Gentle reprocessing of flexible endoscopes, anaesthesia accessories and other thermolabile materials
- Very good material compatibility
- Comprehensive spectrum of activity: bacteria (incl. MRSA, TbB and mycobacteria) and fungi; limited virucidal (incl. HBV, HCV, HIV) and virucidal
- Very economical due to low application concentration
- Can be used in an ultrasonic bath
- DGHM-/VAH-listed and in the IHO virucidal list
- Signal word: Danger
Danger warnings
Danger warnings
H302 + H332 - Harmful if swallowed or if inhaled.
H314 - Causes severe skin burns and eye damage.
H317 - May cause an allergic skin reaction.
H334 - May cause allergy or asthma symptoms or breathing difficulties if inhaled.
H412 - Harmful to aquatic life with long lasting effects.
EUH071 - Corrosive to the respiratory tract.Safety Instructions
P260 - Do not breathe mist.
P280 - Wear protective gloves/protective clothing/eye protection/face protection.
P303 + P361 + P353 - IF ON SKIN (or hair): Take off immediately all contaminated clothing. Rinse skin with water [or shower].
P304 + P340 - IF INHALED: Remove person to fresh air and keep comfortable for breathing.
P305 + P351 + P338 - IF IN EYES: Rinse cautiously with water for several minutes. Remove contact lenses, if present and easy to do. Continue rinsing.
P310 - Immediately call a POISON CENTER/ doctor/…
P273 - Avoid release to the environment.
P501 - Dispose of contents/container to an approved waste disposal facility.Additional warnings
This substance/mixture does not meet the PBT criteria of REACH Regulation, Annex XIII. This substance/mixture does not meet the vPvB criteria of REACH Regulation, Annex XIII. Does not contain PBT/vPvB substances ≥ 0.1% assessed according to REACH Annex XIII. The mixture does not contain substances listed for endocrine disrupting properties according to REACH Article 59(1) or has been determined not to contain substances with endocrine disrupting properties in a concentration equal to or greater than 0.1% according to the criteria of Delegated Regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605.